Lcn2 in the bone and muscle phenotype of the MDX mouse model of Duchenne muscular dystrophy 14 April 2022 by Marco Ponzetti
Growth hormone and/or testosterone trend to reduce vertebral fracture hazard risk in Duchenne muscular dystrophy on chronic glucocorticoids 25 November 2021 by Emely Loscalzo
